Koremasa Hayama

27PUBLICATIONS
70CO-AUTHORS
PhotochemistryAllergyPsychopharmacologyRheumatology and arthritisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 08, 2026
Treatment Guidance for Palmoplantar Pustulosis 2022.

|Jun 05, 2026
Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

|Mar 26, 2026
Comparison of Severity Assessment Methods in Generalized Pustular Psoriasis: A Single-Center Study.

Masafumi Ozaki, Koremasa Hayama, Hideki Fujita

|Feb 19, 2026
Remibrutinib Showed a Favorable Safety Profile and Sustained Efficacy in Japanese Patients with Chronic Spontaneous Urticaria Over 52 Weeks.

Koremasa Hayama, Yuko Chinuki, Akiko Yagami

|Jul 13, 2025
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.

Vivian Y Shi, John R Ingram, Hadar Lev-Tov

|Jan 25, 2024
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.

Takayuki Miyamoto, Kazushi Izawa, Sho Masui

Pageof 5

Frequent Collaborators

13 joint publications

Hideki Fujita

7 joint publications

Tadashi Terui

3 joint publications

Yusuke Niwa

3 joint publications

Natsumi Ikumi